(Q50994560)

English

The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model.

scientific article published on 14 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

1 reference

based on heuristic

inferred from title

vascular disease

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

author name string

Tracey Gaspari

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

Iresha Welungoda

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

Robert E Widdop

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

Richard W Simpson

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

language of work or name

0 references

publication date

14 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

10

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

353-360

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

The role of incretins in glucose homeostasis and diabetes treatment

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

An overview of the pharmacokinetics, efficacy and safety of liraglutide

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Treatment evaluation of liraglutide in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Liraglutide prevents diabetes progression in prediabetic OLETF rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Stabilisation of atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1177%2F1479164113481817

21 January 2018

Identifiers

10.1177/1479164113481817

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23673376

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50994560&oldid=1532098747"